HomeALKYLAMINE › Filing
🔔 Get instant alerts when ALKYLAMINE files quarterly results on BSE Start free trial →

Outcome of Board Meeting - Financial Results

Filed: 04 Aug 2026, 14:25 IST Exchange: BSE Category: Financial Results — Press Release
Press Release - Q1FY27 - Revenue 528.01 Cr +30.2% y-y; Profit after Tax 94.63 Cr +91.3% y-y - Board approved unaudited Q1FY27 results; limited review completed with no qualifications - Re-designation of key directors effective Oct 1, 2026: Chairman to Executive Chairman, two Executive Directors to Joint Managing Directors - New Executive Director - Operations appointed for 5-year term from Apr 1, 2027 - Commission to Non-Executive Directors approved up to 1% of net profits for 5 years from FY28 - Trading window to open from Aug 7, 2026 post results announcement
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 ALKYLAMINE — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add ALKYLAMINE to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Alkyl Amines Chemicals Limited

Important. The summary above is generated automatically from Alkyl Amines Chemicals Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.